COVID-19 vaccination of kids without comorbidities in Olongapo to start Nov. 8 | Inquirer News

COVID-19 vaccination of kids without comorbidities in Olongapo to start Nov. 8

COVID-19 vaccination of kids without comorbidities in Olongapo to start Nov. 8

A minor gets jabbed against COVID-19 during the launch of the pediatric vaccination in Olongapo City on Thursday, November 3. (Photo courtesy of the Olongapo City Information Office)

OLONGAPO CITY—The local government is poised to vaccinate against COVID-19 more eligible children within the 12-17 age group by accommodating those even without comorbidities starting November 8, the city health office said.

Online registration for the scheduled pediatric vaccination is ongoing as the city continues to inoculate its remaining population to achieve herd immunity.

ADVERTISEMENT

On Thursday, the city launched its vaccination for children in the same group but prioritized those with comorbidities, benefiting about 100 minors.

FEATURED STORIES

Another pediatric vaccination is slated for November 5 and will continue from November 8 to 12.

As of Friday, the city has already inoculated 149, 842 residents and 57, 445 of them were already fully vaccinated.

The city has to inoculate 70 percent or 182,000 of its 260,000-population to achieve herd immunity against the viral disease.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.